
Kiromic Biopharma Inc is a biotechnology business based in the US. Kiromic Biopharma Inc shares (KRBP) are listed on the NASDAQ and all prices are listed in US Dollars. Kiromic Biopharma Inc employs 59 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Kiromic Biopharma Inc
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – KRBP – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Kiromic Biopharma Inc stock price (NASDAQ: KRBP)
Use our graph to track the performance of KRBP stocks over time.Kiromic Biopharma Inc shares at a glance
Latest market close | $0.40 |
---|---|
52-week range | $0.23 - $4.97 |
50-day moving average | $0.45 |
200-day moving average | $1.39 |
Wall St. target price | N/A |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.18 |
Buy Kiromic Biopharma Inc shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Kiromic Biopharma Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Kiromic Biopharma Inc price performance over time
Historical closes compared with the close of $0.402 from 2022-07-01
1 week (2022-06-28) | -11.65% |
---|---|
1 month (2022-06-03) | 24.84% |
3 months (2022-04-05) | -53.15% |
6 months (2022-01-05) | -75.19% |
1 year (2021-07-02) | -91.69% |
---|---|
2 years (2020-07-01) | N/A |
3 years (2019-07-01) | N/A |
5 years (2017-07-01) | N/A |
Kiromic Biopharma Inc financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -99.58% |
Return on equity TTM | -204.33% |
Profit margin | 0% |
Book value | $1.29 |
Market capitalisation | $6.3 million |
TTM: trailing 12 months
Kiromic Biopharma Inc share dividends
We're not expecting Kiromic Biopharma Inc to pay a dividend over the next 12 months.
You may also wish to consider:
- BioNTech (BNTX.US) (1.33% forward annual dividend yield)
- Bio-Techne (TECH.US) (0.36% forward annual dividend yield)
Kiromic Biopharma Inc overview
Kiromic BioPharma, Inc. , an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candidate targeting PD-L1. It has license agreements with CGA 369 Intellectual Holdings, Inc. and Longwood University, as well as a research and development collaboration agreement with Molipharma, S. R. L.
Kiromic Biopharma Inc in the news
UPDATE -- Diamond Equity Research to Host Emerging Growth Invitational Virtual Investor Conference on June 23, 2022

UPDATE -- Diamond Equity Research to Host Emerging Growth Invitational Virtual Investor Conference on June 23, 2022
Diamond Equity Research to Host Emerging Growth Invitational Virtual Investor Conference on June 23, 2022
Frequently asked questions
What percentage of Kiromic Biopharma Inc is owned by insiders or institutions?Currently 12.664% of Kiromic Biopharma Inc shares are held by insiders and 12.978% by institutions. How many people work for Kiromic Biopharma Inc?
Latest data suggests 59 work at Kiromic Biopharma Inc. When does the fiscal year end for Kiromic Biopharma Inc?
Kiromic Biopharma Inc's fiscal year ends in December. Where is Kiromic Biopharma Inc based?
Kiromic Biopharma Inc's address is: 7707 Fannin, Houston, TX, United States, 77054 What is Kiromic Biopharma Inc's ISIN number?
Kiromic Biopharma Inc's international securities identification number is: US4976341051
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert